Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist
- PMID: 20188595
- DOI: 10.1016/j.healun.2010.01.007
Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist
Abstract
Background: This study investigated if the degree of cardiac fibrosis and myocyte size at the time of left ventricular assist device (LVAD) implantation predicts the degree of improvement in cardiac function and sustained recovery after LVAD explantation.
Methods: The study included 34 patients who underwent LVAD-off test. LV end-diastolic (LVEDD) and end-systolic diameter (LVESD), LV ejection fraction (LVEF), mean pulmonary artery pressure (mPAP), pulmonary capillary wedge pressure (PCWP), and cardiac index (CI) were measured before LVAD implantation and during LVAD-off test. Myocardial tissue was obtained from the apical core at LVAD implantation.
Results: The degree of cardiac fibrosis had significant correlations with changes in LVEDD (r = -0.725, p < 0.0001), LVESD (r = -0.800, p < 0.0001), LVEF (r = -0.637, p < 0.0001), mPAP (r = -0.569, p = 0.0010), PCWP (r = -0.463, p = 0.0123), and CI (r = -0.544, p = 0.0015). Myocyte size also had significant correlations with changes in LVEDD (r = -0.386, p = 0.0235), LVESD (r = -0.414, p = 0.0141), and LVEF (r = -0.528, p = 0.0015). The LVAD was successfully removed in 9 patients. The degree of cardiac fibrosis and myocyte size in these patients was significantly smaller compared with the patients who did not undergo LVAD removal.
Conclusions: Cardiac fibrosis and myocyte size at the time of LVAD implantation were significant predictors of degree of improvement of cardiac function and the sustained recovery after the LVAD explantation.
Copyright 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.J Heart Lung Transplant. 2006 Jan;25(1):7-15. doi: 10.1016/j.healun.2005.08.001. Epub 2005 Nov 10. J Heart Lung Transplant. 2006. PMID: 16399524
-
Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.J Heart Lung Transplant. 2007 Mar;26(3):230-5. doi: 10.1016/j.healun.2006.08.011. J Heart Lung Transplant. 2007. PMID: 17346624
-
Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.J Surg Res. 2005 Jan;123(1):25-32. doi: 10.1016/j.jss.2004.05.013. J Surg Res. 2005. PMID: 15652947
-
Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.Cardiovasc Res. 2005 Dec 1;68(3):376-86. doi: 10.1016/j.cardiores.2005.06.030. Epub 2005 Jul 18. Cardiovasc Res. 2005. PMID: 16024006 Review.
-
Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.Cardiovasc Pathol. 2014 Jan-Feb;23(1):17-20. doi: 10.1016/j.carpath.2013.06.005. Epub 2013 Aug 6. Cardiovasc Pathol. 2014. PMID: 23928368 Review.
Cited by
-
Weaning from ventricular assist device support after recovery from left ventricular failure with or without secondary right ventricular failure.Cardiovasc Diagn Ther. 2021 Feb;11(1):226-242. doi: 10.21037/cdt-20-288. Cardiovasc Diagn Ther. 2021. PMID: 33708495 Free PMC article. Review.
-
Can right ventricular endomyocardial biopsy predict left ventricular fibrosis beforehand in dilated cardiomyopathy?ESC Heart Fail. 2024 Apr;11(2):1001-1008. doi: 10.1002/ehf2.14642. Epub 2024 Jan 17. ESC Heart Fail. 2024. PMID: 38234242 Free PMC article.
-
Myocardial recovery evaluation from ventricular assist device in patients with dilated cardiomyopathy.ESC Heart Fail. 2022 Aug;9(4):2491-2499. doi: 10.1002/ehf2.13951. Epub 2022 May 10. ESC Heart Fail. 2022. PMID: 35535672 Free PMC article.
-
Novel myocardial markers GADD45G and NDUFS5 identified by RNA-sequencing predicts left ventricular reverse remodeling in advanced non-ischemic heart failure: a retrospective cohort study.BMC Cardiovasc Disord. 2020 Mar 5;20(1):116. doi: 10.1186/s12872-020-01396-2. BMC Cardiovasc Disord. 2020. PMID: 32138671 Free PMC article.
-
[Ventricular long-term support with implantable continuous flow pumps: on the way to a gold standard in the therapy of terminal heart failure].Herz. 2015 Apr;40(2):231-9. doi: 10.1007/s00059-015-4209-3. Herz. 2015. PMID: 25822421 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources